Aquatic Capital Management’s Royalty Pharma RPRX Stock Holding History

Aquatic Capital Management’s Portfolio RPRX Stock Details RPRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$754K	Sell	13,449 -113,778	-89%	-$5.92M	0.03%	643
2026 Q1	$6.1M	Buy	127,227 +23,646	+23%	+$1.04M	0.18%	151
2025 Q4	$4M	Buy	+103,581	New	+$3.95M	0.11%	221
2024 Q2	–	Sell	-11,200	Closed	-$340K	–	1545
2024 Q1	$340K	Buy	+11,200	New	+$330K	0.01%	640
2023 Q3	–	Sell	-79,600	Closed	-$2.45M	–	1588
2023 Q2	$2.45M	Buy	+79,600	New	+$2.7M	0.13%	167
2023 Q1	–	Sell	-177,900	Closed	-$7.04M	–	1685
2022 Q4	$7.04M	Buy	+177,900	New	+$7.43M	0.51%	33

Other funds holding RPRX

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Aquatic Capital Management's RPRX Position: Q2 2026 in Review

Aquatic Capital Management reduced its Royalty Pharma (RPRX) stake by 89% in Q2 2026, selling an estimated $5.92M and leaving 13,449 shares worth $754K. The position accounts for 0.03% of the portfolio, ranked #643.

Aquatic Capital Management first reported a position in RPRX in Q4 2022 and has held it in 6 quarters since. The position peaked at $7.04M in Q4 2022. 643 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

Aquatic Capital Management held 13,449 shares of Royalty Pharma worth $754K as of Q2 2026.
Aquatic Capital Management sold 113,778 Royalty Pharma shares in Q2 2026, an estimated $5.92M.
Royalty Pharma made up 0.03% of Aquatic Capital Management's portfolio in Q2 2026, its #643 holding.
Aquatic Capital Management first reported a position in Royalty Pharma in Q4 2022 and has held it in 6 quarters since.
Aquatic Capital Management's Royalty Pharma position peaked at $7.04M in Q4 2022.
643 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on Aquatic Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.